Almost everyone on a GLP-1 pauses at some point — a surgery, a pregnancy, a coverage gap. The guidance for each is published; here's what it actually says, and what the label requires when you come back.
Verified Aug 11, 2026
Quick answer: pauses are normal and planned for in the official guidance. The one rule that surprises people: after missing 2 or more weekly doses, you restart at a lower dose and build back up — never straight back to your old dose.
The three common reasons to pause
Each grounded in published guidance or the FDA label.
1
Before surgery or a procedure with anesthesia
In 2023, the American Society of Anesthesiologists suggested holding GLP-1s before elective procedures — a week ahead for weekly injections — because slowed stomach emptying raises aspiration risk under anesthesia. In October 2024, updated multi-society guidance shifted the default: most patients can continue their GLP-1, with the highest-risk patients following a 24-hour clear-liquid diet before the procedure instead. Because the guidance moved recently, surgical teams differ in what they ask for.
Next step: Tell your surgical and anesthesia team you take a GLP-1 as soon as the procedure is scheduled, and follow their instruction — they know your risk profile and their protocol.
The Wegovy prescribing information is unambiguous: discontinue at least 2 months before a planned pregnancy, because semaglutide stays in the body a long time, and discontinue immediately when a pregnancy is recognized. Weight loss offers no potential benefit during pregnancy and may harm the fetus, per the label.
Next step: If you're planning a pregnancy, build the 2-month stop into the timeline with your prescriber. If you discover one, stop the medication and call your prescriber now, not at the next appointment.
Losing coverage mid-treatment is common enough that we wrote a separate guide for it — formulary changes, prior authorizations that expire, job changes. The short version: there are official paths back (appeals, exceptions, manufacturer self-pay programs), and a restart after a gap has its own safety rules, covered below.
Next step: See our coverage-lapsed guide for the paths back to coverage, and read the restart rules below before your first dose back.
These rules are from the Wegovy prescribing information's dosing section. Other GLP-1 labels have their own missed-dose rules — the pattern is similar, but confirm yours with your prescriber or pharmacist.
Missed one dose, less than 5 days ago
Take it as soon as possible, then return to your regular weekly day.
Missed one dose, 5 or more days ago
Skip it entirely and take the next dose on your regular day. Doubling up isn't a catch-up — it's an overdose risk.
Missed 2 or more consecutive doses
Don't resume at your old dose. The label says to restart at a lower dose and re-escalate, because gastrointestinal tolerance fades during a gap. Your prescriber picks the restarting dose.
This page summarizes published clinical guidance and FDA labeling. It is not medical advice — decisions about pausing or restarting any medication belong with your prescriber, who knows your history.